How is IsoPSA Different?
Prostate cancer can cause PSA levels to increase, but so can benign factors such as enlargement of the prostate, infections, sexual activity, even undergoing a prostate exam.
Assessing the structure of PSA is more specific and a direct measure of cancer which can help determine if it originated from a cancer cell.
IsoPSA is a simpler, more accurate way to assess risk of having clinically significant prostate cancer
IsoPSA is a blood test for men with elevated total
PSA ≥ 4ng/mL that identifies structural differences
in PSA proteins that are expressed by cancer.
IsoPSA can clarify prostate cancer risk, enabling better biopsy decisions for patients who are either biopsy naïve or who have had prior negative biopsy.
How is IsoPSA Better?
If you are a Healthcare Provider interested in offering IsoPSA testing to your patients, contact us:
CONTRAINDICATIONS:
IsoPSA is not indicated for men under 50 years of age, men who have had a recent (<72 hours) prostate manipulation, including DRE; recent (<2 weeks) UTI and/or prostatitis; recent (<30 days) prostate surgery, urinary catheterization, prostate infarction, or endoscopic evaluation; or diagnosis of prostate cancer or other urinary tract malignancy.
If you are a Healthcare Provider interested in offering IsoPSA testing to your patients, contact us
1 Klein, et al., Urol Oncol. 2022 Sep;40(9):408.e9-408.e18.
2 Benidir et al., Urology. 2023 Jun;176:115-120.
3 Scovell et al., Urology. 2023 May;175:132-136.
4 Scovell, et al., Urol Pract. 2022 Mar;9(2):173-180
* CGS LCD L39284